Poster Exhibition 1

[PE-059] Guselkumab efficacy and safety in East Asian participants with moderate to severely active Crohn’s disease: Subgroup analysis of the GALAXI-2 and GALAXI-3 Phase 3 studies

*Hiroshi Nakase¹, Baili Chen², Qian Cao³, Katsuyoshi Matsuoka⁴, Tadakazu Hisamatsu⁵, Dong Il Park⁶, Brian Wahking⁷, Wai Chun Yiu⁸, Jianmin Zhuo⁹, Minhu Chen² (1. Sapporo Medical University School of Medicine, Sapporo, Japan, 2. The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China, 3. Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China, 4. Toho University Sakura Medical Center, Chiba, Japan, 5. Kyorin University School of Medicine, Tokyo, Japan, 6. Kangbuk Samsung Hospital, Sungkyunkwan University, Seoul, Republic of Korea, 7. Janssen Asia Pacific, Singapore , 8. Janssen Research & Development, LLC, Spring House, PA, USA, 9. Janssen China R&D, Shanghai, China)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.